Metabolic effect of telmisartan and losartan in peritoneal dialysis patients
Not Applicable
- Conditions
- peritoneal dialysis patients
- Registration Number
- JPRN-C000000383
- Lead Sponsor
- Department of Internal Medicine,Osaka University School of Medicine Devision of Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)morning blood pressure < 125/75mmHg in a sitting position without any antihypertensive 2)patients with hyperkalemia(K>6.0 mEq/l)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effect on lipid profile and insulin sensitivity;waist,BMI,T-Cho,TG,LDL-C,leptin,HOMA-IR,values of glucose and insulin in the oral glucose tolerance test
- Secondary Outcome Measures
Name Time Method 1)effect on inflammation;serum hsCRP,IL- 6,TNFarfa 2)effect on blood pressure;ambulatory blood pressure monitoring 3)effect on residual renal function; renal Ccr,urine protein